← Back to News · 1 outlet · Story cluster #3843

enGene Announces Updated Interim Results From LEGEND Pivotal Cohort

How different outlets framed the same story — bias, verdict, and framing side by side.

🤖 D.R.A.F.T. Summary

54% complete response (CR) rate at any time; 43% six‑month CR rate Low rate of progression to muscle-invasive or higher disease (3.2%) Low percentage of patients experienced treatment-related adverse events (TRAEs) (55%), nearly all of which were mild Low percentage of patients experienced TRAEs leading to treatment interruption (2.4%) or discontinuation (2.4%) Kaplan-Meier estimate of... The post enGene Announces Updated Interim Results From LEGEND Pivotal Cohort appeared first on Montreal Gazette.

Outlets covering this story

Montreal Gazette CENTER

Only one perspective covered this story — no diversity detected

📰

Side-by-Side Outlet Comparison — Starter+

See how 1 outlets framed this story — bias by source, F.A.C.T. framing analysis, and verdict side by side.

Unlock with Starter →

See plans